ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 208 filers reported holding ACADIA PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $6,633,000 | -56.6% | 157,000 | -56.0% | 0.83% | -34.1% |
| Q4 2019 | $15,272,000 | +371.5% | 357,000 | +296.7% | 1.26% | +151.8% |
| Q3 2019 | $3,239,000 | -36.7% | 90,000 | -47.1% | 0.50% | -16.8% |
| Q4 2017 | $5,119,000 | +28.7% | 170,000 | +36.0% | 0.60% | -7.1% |
| Q3 2016 | $3,976,000 | -5.2% | 125,000 | -16.7% | 0.65% | -28.8% |
| Q1 2016 | $4,194,000 | +17.6% | 150,000 | +50.0% | 0.91% | +74.1% |
| Q4 2015 | $3,565,000 | – | 100,000 | – | 0.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |